Vanderbilt-Ingram Cancer Center Archive — Page 19 of 28

Vanderbilt-Ingram website >

Portrait of a smiling woman with long brown hair and glasses, wearing a patterned sweater and jeweled necklace, in a laboratory or office setting.
January 27, 2022

New fund supports appendiceal cancer research

By Tom Wilemon
Portrait of Cathy Eng, MD, wearing a white medical coat over a pink patterned blouse.
January 25, 2022

Comprehensive framework outlined for addressing early-onset colorectal cancer research

New research from Vanderbilt sets a comprehensive framework for addressing research challenges and patient needs for people under 50 with colorectal cancer.

By Tom Wilemon
Two masked nurses stand arm in arm in a clinic room, wearing black cardigans and employee badges; one wears black scrubs and the other blue scrubs.
January 24, 2022

Donna Atherton and Karen Pinkard are nurses who have worked together for years. The day Karen’s heart stopped at work, Donna was there to save her life.

A lot of people worked to save her life and help her recover. Thanks to them, Karen Pinkard is back at work.

By Tom Wilemon
VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
January 19, 2022

Clinical score can guide PRRT therapy decisions for neuroendocrine tumors

A clinical score system developed by researchers at Vanderbilt-Ingram Cancer Center (VICC) has been validated that can guide peptide receptor radionuclide therapy treatment decisions.

By Tom Wilemon
VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
January 5, 2022

Drug modifies epigenome in aggressive brain tumors: study

A folic acid-like drug changed a DNA process within brain tumors of glioblastoma patients, according to results from a phase 1 clinical trial.

By Tom Wilemon
White disposable surgical mask labeled “COVID-19” on a light blue background.
December 24, 2021

Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate

New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death.

By Tom Wilemon